151 results on '"Egeberg, Alexander"'
Search Results
2. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
3. Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure
4. Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60
5. Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
6. Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials
7. Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study
8. Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)
9. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study
10. Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa
11. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
12. Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
13. Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea
14. Elevated plasma levels of calcitonin gene‐related peptide in individuals with rosacea: A cross‐sectional case–control study
15. Incidence and geographic differences in keratinocyte carcinoma and Bowen's disease in office‐based dermatological practice between 2013 and 2022: A nationwide Danish registry‐based study.
16. Increased loss‐of‐function filaggrin gene mutation prevalence in atopic dermatitis patients across northern latitudes indicates genetic fitness: A systematic review and meta‐analysis.
17. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis
18. Fatigue is associated with disease severity in adult patients with hidradenitis suppurativa
19. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
20. Drug Survival of Biologics in Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis
21. Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective
22. Characteristics of Patients With Psoriasis Treated With Various Biologics – A Danish Cohort Study
23. 534 - Incidence of venous thromboembolic events and atherosclerotic cardiovascular disease risk factors in adolescents and adults with atopic dermatitis in Denmark: a population-based cohort study
24. Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study
25. The agreement between consumer-driven self-assessment of psoriasis severity and physician-assessed severity based on patient-taken photographs is weak: cross-sectional study
26. Estimating the burden of skin diseases using patient‐reported daily time trade‐off as a measure of disease impact and unmet needs
27. Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: a Danish population-based cohort study.
28. The Agreement between Consumer-Driven Self-Assessment of Psoriasis Severity and Physician-Assessed Severity Based on Patient-Taken Photographs Is Weak: A Cross-Sectional Study.
29. Impact of the COVID-19 Pandemic on Care for Patients With Skin Cancer.
30. Predicting Psoriatic Arthritis in Psoriasis Patients – A Swiss Registry Study.
31. Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross‐sectional validation and registry‐based study.
32. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).
33. Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement
34. Atopic dermatitis phenotypes based on cluster analysis of the Danish Skin Cohort.
35. Use of systemic and biological therapy in patients with moderate-to-severe psoriasis.
36. Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nurses.
37. Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
38. Attitudes towards clinical research in adult patients with hidradenitis suppurativa during the COVID-19 pandemic: Insights from a survey.
39. Risk for COVID-19 Infection in Patients With Vitiligo.
40. Prevalence of ichthyoses in Denmark: a nationwide registry-based study.
41. Topical corticosteroids in the era of new topical therapies: Balancing efficacy and safety for long‐term use.
42. Paradoxical psoriasis after dupilumab treatment of prurigo nodularis successfully treated with adalimumab
43. 52793 Usage of digital information technologies in patients with hidradenitis suppurativa.
44. 52089 Patient characteristics associated with prescription of omalizumab at first visit among hospital outpatients with chronic urticaria.
45. 51843 Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa: results from the 700 first patients of the Copenhagen Hidradenitis Suppurativa Cohort Study.
46. 51561 The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with disease severity, asthma and rhinitis.
47. 51826 PRO-C22 - A Novel Serological Biomarker of Tissue Damage is Associated with Disease Severity, Disease Activity, and Systemic Inflammation in Patients with Hidradenitis Suppurativa.
48. 51791 Guselkumab improves psoriatic skin and HRQoL outcomes across BMI subgroups, including patients with involvement of hard-to-treat areas: results from the real-world PERSIST study.
49. 51783 A novel biomarker of type VII collagen degradation is increased in patients with atopic dermatitis and lowered when receiving immunosuppressant treatment.
50. Incidence of venous thromboembolic events and atherosclerotic cardiovascular disease risk factors in adolescents and adults with atopic dermatitis in Denmark: a population-based cohort study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.